Delivery Order SPE2DB20D2104-SPE2DB25FMXKG
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,871.27 to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. This firm fixed-price, competitively awarded contract was finalized on August 14, 2025, with an ultimate completion date of August 15, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,591.48 to AmerisourceBergen Drug Corp for Dexcom G7 sensors. This is a firm fixed price, competitively awarded contract with an ultimate completion date of July 21, 2025. The award was made on July 18, 2025, with no set-aside designation. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,071.44 to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of September 18, 2025. This non-competitive, firm fixed-price delivery order was issued under a larger indefinite delivery contract (IDC) vehicle, representing a routine procurement of continuous glucose monitoring devices for military healthcare support. The contract was awarded to AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $4,981.76 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on September 16, 2025, with an ultimate completion date of September 17, 2025. This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The order will be fulfilled from the vendor's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,250.55 for Dexcom G7 sensors, with an ultimate completion date of September 15, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $1,546.80 to AmerisourceBergen Drug Corp for the supply of Dexcom G7 sensors. This contract was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of August 12, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $4,124.80 to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. This firm fixed price delivery order, effective through August 12, 2025, represents a competitively awarded, non-set-aside procurement issued on August 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,007.81 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on June 25, 2025, with completion scheduled for June 26, 2025. This firm fixed price, non-set-aside delivery order represents a continuation of federal medical supply procurement through the company's existing contract vehicle with DLA. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical and medical device distributor...
- The Defense Logistics Agency awarded a delivery order valued at $3,361.44 to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. The contract is firm fixed price with no set-aside designation and carries an ultimate completion date of August 6, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $1,023.62 firm fixed-price delivery order for Dexcom G7 sensors, with an ultimate completion date of September 5, 2025. This competitively awarded contract, issued on September 4, 2025, represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMXKGDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,870.53 to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and primary location for federal medical supply distribution. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare systems. As the prime contractor on the SPE2DX IDC, the company supplies a comprehensive range of pharmaceutical products and medical devices across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Dexcom G7 sensors being procured under this delivery order are continuous glucose monitoring devices used for diabetes management, aligning with AmerisourceBergen's established portfolio of diabetes-related pharmaceutical products and medical supplies delivered through the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 8/11/25 |